Literature DB >> 8428085

Soluble-type hepatobiliary contrast agents for MR imaging.

C de Haën1, L Gozzini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8428085     DOI： 10.1002/jmri.1880030130

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN： 1053-1807            Impact factor:   4.813


× No keyword cloud information.
  8 in total

Review 1.  [Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].

Authors:  C Stroszczynski; G Gaffke; M Gnauck; F Streitparth; G Wieners; E Lopez-Häninnen
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

2.  Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.

Authors:  C S Peña; S Saini; R L Baron; B A Hamm; G Morana; R Caudana; A Giovagnoni; A Villa; A Carriero; D Mathieu; M W Bourne; M A Kirchin; G Pirovano; A Spinazzi
Journal:  Korean J Radiol       Date:  2001 Oct-Dec       Impact factor: 3.500

3.  Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.

Authors:  Ricarda Rühl; Lutz Lüdemann; Anna Czarnecka; Florian Streitparth; Max Seidensticker; Konrad Mohnike; Maciej Pech; Peter Wust; Jens Ricke
Journal:  Radiat Oncol       Date:  2010-05-27       Impact factor: 3.481

4.  Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.

Authors:  Yulri Park; Seong Hyun Kim; Seung Hoon Kim; Yong Hwan Jeon; Jongmee Lee; Min Ju Kim; Dongil Choi; Won Jae Lee; Heejung Kim; Ji Hyun Koo; Hyo Keun Lim
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

Review 5.  [Contrast agents in MRT. Substance, effects, pharmacology and validity].

Authors:  P Reimer; R Vosshenrich
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

Review 6.  Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Authors:  Peter Reimer; Günter Schneider; Wolfgang Schima
Journal:  Eur Radiol       Date:  2004-02-25       Impact factor: 5.315

7.  Positron Emission Tomography-Magnetic Resonance Imaging Pharmacokinetics, In Vivo Biodistribution, and Whole-Body Elimination of Mn-PyC3A.

Authors:  Iris Yuwen Zhou; Ian A Ramsay; Ilknur Ay; Pamela Pantazopoulos; Nicholas J Rotile; Alison Wong; Peter Caravan; Eric M Gale
Journal:  Invest Radiol       Date:  2021-04-01       Impact factor: 10.065

8.  Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI.

Authors:  M F Wendland; M Saeed; K Lauerma; N Derugin; J Mintorovitch; F M Cavagna; C B Higgins
Journal:  Magn Reson Med       Date:  1997-03       Impact factor: 4.668
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.